FDA Rejects Oral Treatment for Type 1 Diabetes – Wall Street Journal

Business News

  1. FDA Rejects Oral Treatment for Type 1 Diabetes  Wall Street Journal
  2. FDA stiff-arms Sanofi and Lexicon’s Type 1 diabetes hopeful Zynquista  FiercePharma
  3. FDA snubs Sanofi, Lexicon on their pitch for SGLT1/2 diabetes drug sotagliflozin, companies mum on what went wrong  Endpoints News
  4. Why Zuora, Greenbrier, and Lexicon Pharmaceuticals Slumped Today  Motley Fool
  5. Diabetes Treatment: Sanofi Slips After FDA Rejects Application  Investor’s Business Daily
  6. View full coverage on Google News

Source: Business News

/by